The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia

Author(s):
Brooks, S.; Jacobs, G.E.; Boer, P. de; Kent, J.M.; Nueten, L. van; Amerongen, G. van; Zuiker, R.; Kezic, I.; Luthringer, R.; Ark, P. van der; Gerven, J.M.A. van (0000-0002-1444-7415); Drevets, W.
Published
2019
Publication type
Article / Letter to editor
Depressioninsomniaorexin 2 antagonist
Date issued
2019-02-28
Language
English
Is part of
Journal of Psychopharmacology (2019), Vol. 33, no. 2, p. 202-209
hdl
1887/119782
doi
10.1177/0269881118822258